• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision IR
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision IR
  • SocialBoost
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Unjury® Protein Introduces Protect & Restore Advanced Protein+

Unjury Medical Quality Protein

News provided by

Unjury

Jun 20, 2024, 09:58 ET

Share this article

Share toX
SHARE A PRE-MADE POST

Share this article

Share toX
SHARE A PRE-MADE POST

First-of-its-kind co-therapy to reduce side effects of GLP-1 RAs

MIDDLETOWN, Conn., June 20, 2024 /PRNewswire/ -- Unjury Protein, a leader in medical-quality protein, today announced the launch of Protect & Restore Advanced Protein+ – the first clinically supported medical food and co-therapy for GLP-1 RA anti-obesity medications (AOMs) – specifically designed to minimize side effects often experienced during GLP-1 RA use.

Continue Reading
Unjury Protect & Restore Advanced Protein+ – the first clinically supported medical food and co-therapy for GLP-1 RA anti-obesity medications (AOMs)
Unjury Protect & Restore Advanced Protein+ – the first clinically supported medical food and co-therapy for GLP-1 RA anti-obesity medications (AOMs)

An estimated one in eight American adults have taken a GLP-1 drug.i Although GLP-1 RA AOMs can help people achieve clinically significant weight loss, up to 40% of individuals report side effects, including the loss of lean muscle, nutrient deficiencies, digestive discomfort, metabolic dysfunction, and nausea.ii, iii

The first two abstracts supporting the clinical benefits of Protect & Restore Advanced Protein+ as a GLP-1 co-therapy were presented during last week at the American Society of Metabolic and Bariatric Surgery (ASMBS) Annual Meeting in San Diego.

"Protect & Restore Advanced Protein+ is a clinically unique and effective nutrient solution designed to support the millions of patients turning to GLP-1 RAs for weight management support," said John P. Troup, Ph.D., Chief Science Officer, Unjury and Blueroot Health. "Early clinical research is extremely encouraging to support beneficial use of Protect & Restore as a co-therapy with GLP-1 RA medications. Larger clinical trials are currently in progress." iv

Protect & Restore Advanced Protein+ is a clinically studied medical food designed to support the safe and comfortable use of GLP-1 RA medications by addressing four key nutrient-based issues of support:

  • Promotes muscle mass and strength – The unique whey protein blend with leucine and branched-chain amino acids has been shown in scientific studies to be up to 5x more effective at building muscle than whey protein alone. This benefit can help minimize potential muscle loss during treatment.v, vi, v, vi
  • Replenishes key nutrients – Protect & Restore Advanced Protein+ delivers 17 essential vitamins and minerals to help support the daily nutrient requirements and ensure optimal nutrition.
  • Promotes healthy digestive function – Soluble and insoluble fibers can support stomach motility and minimize digestive discomfort, such as bloating and constipation.
  • Reduces nausea – Plant phytonutrients can ease nausea,vi, viii a common side effect reported with GLP-1 RA treatment.

Protect & Restore Advanced Protein+ offers a clean product profile and is formulated without artificial flavors, sweeteners, or dyes, making it suitable for a range of patients. It is available in Tropical Twist and Chocolate Mocha flavors and offered in a 15-serving tub (MSRP: $59.95).

"Blueroot Health brands are committed to driving product innovation that significantly enhances patient wellness," said Jane Pemberton, CEO and President. "Unjury's latest advancement provides healthcare practitioners with a crucial tool to improve patients' quality of life."

For more information visit unjury.com.

 About Unjury Medical Quality Protein
Unjury® is a leading provider of high-quality protein products recommended at America's top-rated hospitals. Founded by a dietitian, Unjury is dedicated to supporting health and wellness at every stage, with trusted, effective and great-tasting proteins, meal replacements and medical foods, developed with the highest quality ingredients and recommended by healthcare providers for more than 15 years. Unjury is part of the Blueroot Health Family of Brands.

For more information, visit unjury.com.

About Blueroot Health™ 
Blueroot Health is a consumer health company growing a diverse portfolio of brands that fuel lasting happiness and health for people and planet. The company's industry-leading brands – including Vital Nutrients®,  Fairhaven Health®,   Hyperbiotics®,  Bariatric Fusion® and Unjury® – offer a suite of clean, innovative, and clinically relevant nutritional supplements that work. The portfolio includes specialized solutions for women's health, metabolic and bariatric health, and precision probiotics, as well as a full spectrum of clinically relevant formulas trusted by healthcare practitioners, patients, and consumers worldwide. Blueroot Health is committed to making a lasting, positive impact on the communities it serves, without leaving a negative footprint on the planet.   

For more information, visit blueroothealth.co. 

Media Contact:
Erin Anthony
[email protected]

i Source: KFF Health Tracking Poll. April 23-May 1, 2024.
ii Gorgojo-Martínez JJ et al. J Clin Med. 2023;12(1):145.
iii Zhang X. J Cachexia Sarcopenia Muscle. 2021;12(6):1368-1379.
iv Troup JP, Koscinski M. ASMBS Annual Meeting Abstract. 2024.
v Coker RH et al. Clin Nutr. 2019;38(6):2821-2826.
vi Wolfe RR. J Int Soc Sports Nutr. 2017;14:30.
v Wolfe RR.  J Nutr. 2002;132:3219S-3224S.
vi Symons TB et al.  J Am Diet Assoc. 2009;109(9):152-1586.
vii Palatty PL et al. Crit Rev Food Sci Nutr. 2013;53(7):659-669.
viii Hu ML et al. 2011;17(1):105-110.

SOURCE Unjury

Modal title

Contact PR Newswire

  • Call 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Partnerships
  • Media Inquiries

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • Asia
  • APAC
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Korea
  • Italy
  • Japan
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
PR Newswire Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2024 Cision US Inc.